The former chief financial officer of delisted Traditional Therapy Clinics has been sentenced to one year and ten months in prison after pleading guilty to market manipulation charges relating to transactions intended to create an artificial share price for the traditional therapy clinic company.
A “belligerent” Crown Melbourne lied to investigators probing the arrests of 19 of its China-based staff, and the casino operator could face charges of contempt for failing to respond to demands for documents by the gaming watchdog, an inquiry has been told.
Ernst & Young has resigned from its role as Omni Bridgeway’s long-time auditor after determining a class action against it that’s being backed by the litigation funder could threaten its independence.
Lawyers retained by former attorney-general Christian Porter have accused the ABC of making “improper” allegations against Porter’s counsel, who is facing calls for her to return her brief to act for him in defamation proceedings against the national broadcaster.
Chinese lender Aoyin wants to join Baker McKenzie to its claims against PwC over a failed bid to launch the first Chinese bank incorporated in Australia, after advice documents from the law firm were uncovered in a last-minute privilege fight.
Queensland rail operator Aurizon has been sued for breach of contract and “flagrant” copyright infringement for allegedly using software produced by French software giant Dassault without the necessary licence.
Fossil fuel giant Shell Australia has partially won a challenge to a tax office decision denying deductions claimed over an acquisition the increased the company’s stake in Woodside Energy’s Browse Basin gas exploration joint venture project.
Employees of Romeo’s will be sent a corrected opt-out notice in class actions against the supermarket chain after it emerged that the company’s senior managers may have made unauthorised contact with group members about their participation in the proceedings.
Gym chain Viva Leisure is reportedly facing a potential class action alleging the company has engaged in unconscionable conduct in its dealings with a group of franchisees.
The lead applicant in a class action against Bayer over its allegedly defective Essure contraceptive devices has won court approval to drop her consumer law claims against the German drug maker, with a judge agreeing that the plaintiff’s defect and negligence claims had a better chance of succeeding.
For information on rights and reprints, contact subscriptions@lawyerly.com.au
